EE9600067A - S(+)-etodolaki suu kaudu manustatavad ravimvormid ja meetod nende valmistamiseks - Google Patents

S(+)-etodolaki suu kaudu manustatavad ravimvormid ja meetod nende valmistamiseks

Info

Publication number
EE9600067A
EE9600067A EE9600067A EE9600067A EE9600067A EE 9600067 A EE9600067 A EE 9600067A EE 9600067 A EE9600067 A EE 9600067A EE 9600067 A EE9600067 A EE 9600067A EE 9600067 A EE9600067 A EE 9600067A
Authority
EE
Estonia
Prior art keywords
etodolac
preparation
dosage forms
oral dosage
oral
Prior art date
Application number
EE9600067A
Other languages
English (en)
Inventor
George Humber Leslie
Louis Reuter Gerald
Original Assignee
American Home Products Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Products Corporation filed Critical American Home Products Corporation
Publication of EE9600067A publication Critical patent/EE9600067A/et

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A61K9/0058—Chewing gums
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Cosmetics (AREA)
EE9600067A 1995-06-13 1996-06-12 S(+)-etodolaki suu kaudu manustatavad ravimvormid ja meetod nende valmistamiseks EE9600067A (et)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US17195P 1995-06-13 1995-06-13

Publications (1)

Publication Number Publication Date
EE9600067A true EE9600067A (et) 1996-12-16

Family

ID=21690247

Family Applications (1)

Application Number Title Priority Date Filing Date
EE9600067A EE9600067A (et) 1995-06-13 1996-06-12 S(+)-etodolaki suu kaudu manustatavad ravimvormid ja meetod nende valmistamiseks

Country Status (26)

Country Link
US (1) US5958445A (et)
EP (1) EP0748628A3 (et)
JP (1) JPH093071A (et)
KR (1) KR970000228A (et)
CN (1) CN1152434A (et)
AR (1) AR003435A1 (et)
AU (1) AU711853B2 (et)
BR (1) BR9602758A (et)
CA (1) CA2178686A1 (et)
CO (1) CO4700456A1 (et)
CZ (1) CZ170296A3 (et)
EA (1) EA000047B1 (et)
EE (1) EE9600067A (et)
HU (1) HUP9601635A3 (et)
IL (1) IL118636A (et)
IN (1) IN182040B (et)
MA (1) MA23907A1 (et)
NO (1) NO962491L (et)
NZ (1) NZ286791A (et)
PE (1) PE10898A1 (et)
PL (1) PL314732A1 (et)
SG (1) SG46737A1 (et)
SK (1) SK74396A3 (et)
SV (1) SV1996000051A (et)
TR (1) TR199600499A2 (et)
ZA (1) ZA964928B (et)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0974366T3 (da) 1997-03-28 2007-01-29 Eisai Co Ltd Orale, farmaceutiske præparater med nedsat bitterhed ved maskering
AU6589200A (en) * 1999-09-10 2001-04-17 Ranbaxy Laboratories Limited Extended release formulation of etodolac
WO2001021178A2 (en) * 1999-09-22 2001-03-29 Akzo Nobel, N.V. Method of treating cognitive dysfunction syndrome in dogs and chewable tablet for dogs
KR100416242B1 (ko) * 1999-12-22 2004-01-31 주식회사 삼양사 약물전달체용 생분해성 블록 공중합체의 액체 조성물 및이의 제조방법
ATE437632T1 (de) 2000-03-01 2009-08-15 Eisai R&D Man Co Ltd Schnellzerfallende polyvinylhaltige tablette
US6514537B1 (en) 2000-06-02 2003-02-04 Cumberland Swan Holdings, Inc. Magnesium citrate solution
CN1638739A (zh) * 2000-08-18 2005-07-13 法玛西雅厄普约翰美国公司 治疗成瘾性障碍的化合物
EP1309315B1 (en) * 2000-08-18 2006-06-14 Pharmacia Corporation Rapidly disintegrating oral formulation of valdecoxib
SK11802003A3 (sk) * 2001-02-27 2004-06-08 Ranbaxy Laboratories Limited Rýchlo rozpustné tablety enzýmového inhibítora cyklooxygenázy-2
AP2004002999A0 (en) * 2001-09-26 2004-03-31 Pharmacia Corp Organoleptically acceptable intraorally disintegrating compositions
AU2002357506A1 (en) * 2001-12-25 2003-07-15 Takeda Chemical Industries, Ltd. Acid-containing preparations
US20040037869A1 (en) 2002-08-16 2004-02-26 Douglas Cleverly Non-animal product containing veterinary formulations
US20040151759A1 (en) * 2002-08-16 2004-08-05 Douglas Cleverly Non-animal product containing veterinary formulations
TWI366442B (en) 2003-07-30 2012-06-21 Novartis Ag Palatable ductile chewable veterinary composition
GB0320854D0 (en) 2003-09-05 2003-10-08 Arrow No 7 Ltd Buccal drug delivery
KR101074374B1 (ko) * 2004-01-29 2011-10-17 가부시키가이샤 메드렉스 소염진통 외용제
US20080255104A1 (en) * 2004-05-04 2008-10-16 Equitech Corporation Nsaid Compositions
BRPI0602825A2 (pt) * 2006-06-23 2012-04-24 Rhodia Br Ltda formulação de pó efervescente auto-refrigerante para bebidas e uso de formulação em pó efervescente
US20090258823A1 (en) * 2006-12-08 2009-10-15 George Caroline L S Composition and methods for the prevention and treatment of gastrointestinal infections
TR201902125T4 (tr) 2012-02-06 2019-03-21 Merial Inc Si̇stemi̇k olarak etki̇ eden akti̇f ajanlari i̇çeren parazi̇ti̇si̇dal oral veteri̇nerli̇ğe ai̇t bi̇leşi̇mler, bunlarin yöntemleri̇ ve kullanimlari
AU2013245008B2 (en) 2012-04-04 2017-03-30 Intervet International B.V. Soft chewable pharmaceutical products
WO2013169218A1 (en) * 2012-05-08 2013-11-14 Mahmut Bilgic Pharmaceutical compositions of s-etodolac

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2260148A (en) * 1939-06-19 1941-10-21 Frank H Fleer Corp Chewing gum material
GB971700A (en) * 1961-02-02 1964-09-30 Boots Pure Drug Co Ltd Anti-Inflammatory Agents
US3939178A (en) * 1971-06-01 1976-02-17 American Home Products Corporation Certain pyrano [3,4-b]indoles and thiopyrano[3,4-b]indoles
GB1548022A (en) * 1976-10-06 1979-07-04 Wyeth John & Brother Ltd Pharmaceutial dosage forms
CA1097233A (en) * 1977-07-20 1981-03-10 George K. E. Gregory Packages
US4265847A (en) * 1978-03-30 1981-05-05 Kirby Pharmaceuticals Ltd Tabletting process
US4520203A (en) * 1983-08-16 1985-05-28 American Home Products Corporation Resolution of (±)-1,8-diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indole-1-acetic acid using cinchonine
US4639368A (en) * 1984-08-23 1987-01-27 Farmacon Research Corporation Chewing gum containing a medicament and taste maskers
US4879108A (en) * 1985-12-20 1989-11-07 Warner-Lambert Company Confectionery delivery system for antipyretics
US4764378A (en) * 1986-02-10 1988-08-16 Zetachron, Inc. Buccal drug dosage form
DE3669103D1 (de) * 1986-11-14 1990-04-05 Puetter Medice Chem Pharm Ibuprofen enthaltendes arzneimittel.
US4800087A (en) * 1986-11-24 1989-01-24 Mehta Atul M Taste-masked pharmaceutical compositions
US4835187A (en) * 1987-06-15 1989-05-30 American Home Products Corporation Spray dried ibuprofen
US4835186A (en) * 1987-06-15 1989-05-30 American Home Products Corporation Spray dried ibuprofen
US4788220A (en) * 1987-07-08 1988-11-29 American Home Products Corporation (Del.) Pediatric ibuprofen compositions
US4851444A (en) * 1987-07-10 1989-07-25 Analgesic Associates Onset-hastened/enhanced analgesia
IE60311B1 (en) * 1987-09-24 1994-06-29 American Home Prod Sustained release etodolac
US4861797A (en) * 1987-10-15 1989-08-29 Oratech Pharmaceutical Development Corporation Liquid ibuprofen compositions and methods of making them
US4851226A (en) * 1987-11-16 1989-07-25 Mcneil Consumer Products Company Chewable medicament tablet containing means for taste masking
US4835188A (en) * 1987-12-08 1989-05-30 American Home Products Corporation Spray dried ibuprofen
US4942039A (en) * 1989-05-09 1990-07-17 Miles Inc. Effervescent analgesic antacid composition having reduced sodium content
GB8909793D0 (en) * 1989-04-28 1989-06-14 Beecham Group Plc Pharmaceutical formulation
US5084278A (en) * 1989-06-02 1992-01-28 Nortec Development Associates, Inc. Taste-masked pharmaceutical compositions
US5190981A (en) * 1989-08-17 1993-03-02 Sepracor Inc. Formulation containing S(+) enantiomer of flurbiprofen or ketoprofen and method of use for oral administration for prevention and treatment of bone loss associated with periodontal disease
US5380535A (en) * 1991-05-28 1995-01-10 Geyer; Robert P. Chewable drug-delivery compositions and methods for preparing the same
AU3806393A (en) * 1992-03-13 1993-10-05 Sepracor, Inc. Antipyretic and analgesic methods and compositions containing optically pure r-etodolac
GB9224021D0 (en) * 1992-11-16 1993-01-06 Boots Co Plc Effervescent compositions
US5458879A (en) * 1994-03-03 1995-10-17 The Procter & Gamble Company Oral vehicle compositions

Also Published As

Publication number Publication date
EA199600029A2 (ru) 1996-12-30
EA000047B1 (ru) 1998-04-30
IL118636A0 (en) 1996-10-16
CN1152434A (zh) 1997-06-25
CA2178686A1 (en) 1996-12-14
AU5588096A (en) 1997-01-02
IL118636A (en) 2000-02-17
CO4700456A1 (es) 1998-12-29
AU711853B2 (en) 1999-10-21
KR970000228A (ko) 1997-01-21
ZA964928B (en) 1997-12-10
SV1996000051A (es) 1997-02-17
EA199600029A3 (ru) 1997-03-31
IN182040B (et) 1998-12-12
HUP9601635A2 (en) 1997-04-28
BR9602758A (pt) 1998-04-22
JPH093071A (ja) 1997-01-07
SK74396A3 (en) 1997-04-09
EP0748628A3 (en) 1997-04-23
TR199600499A2 (tr) 1996-12-21
HUP9601635A3 (en) 2000-06-28
US5958445A (en) 1999-09-28
MA23907A1 (fr) 1996-12-31
HU9601635D0 (en) 1996-08-28
AR003435A1 (es) 1998-08-05
EP0748628A2 (en) 1996-12-18
SG46737A1 (en) 1998-02-20
PL314732A1 (en) 1996-12-23
NZ286791A (en) 1998-01-26
NO962491D0 (no) 1996-06-12
CZ170296A3 (en) 1997-04-16
PE10898A1 (es) 1998-03-20
NO962491L (no) 1996-12-16

Similar Documents

Publication Publication Date Title
EE9600067A (et) S(+)-etodolaki suu kaudu manustatavad ravimvormid ja meetod nende valmistamiseks
NO981085L (no) Tannbörste og fremgangsmåte for dens fremstilling
DE69615887D1 (de) Oral anzuwendende Arzneizubereitung enthaltend Olanzapin
NO964212D0 (no) Ny oral farmasöytisk doseringsform
ZA969001B (en) Method compositions and kits for increasing the oral bioavailability of pharmaceutical agents
HUP9900457A3 (en) Method, compositions and kits for increasing the oral bioavailability of pharmaceutical agents
AU6693696A (en) Quantitative dental caries detection system and method
EE9600068A (et) S(+)-ibuprofeeni suu kaudu manustatavad ravimvormid
FI973426A0 (fi) Bentsopyraania sisältävät yhdisteet ja menetelmä niiden valmistamiseksi
AR002347A1 (es) Hilo dental y método para su fabricación
FI962445A0 (fi) Paroksetiinitabletteja ja menetelmä niiden valmistamiseksi
NO970293D0 (no) Substituerte camptotecinderivater og fremgangsmåte for dens fremstilling
EE03778B1 (et) Vähivaktsiin ja selle valmistamismeetod
DE69305064D1 (de) Präparat und verfahren zur oralen hygiene
DE59608344D1 (de) Interdental-Keil
DE59608606D1 (de) Cyclosprorin(e) enthaltende pharmazeutische zubereitung zur oralen applikation und verfahren zu ihrer herstellung
FR2732343B1 (fr) Composition de maltitol et son procede de preparation
DE59610705D1 (de) Pharmazeutische präparate zur oralen anwendung und verfahren zu ihrer herstellung
DE29509919U1 (de) Präparationsset für Dentalzwecke
KR970000226A (ko) S-이부프로펜의 경구용 제형
ITMI951159A0 (it) Cicloesanocefalosporine e procedimento per la loro preparazione
KR970015941U (ko) 구두골
NO952658D0 (no) Tann-og munnpleiemiddel og fremgangsmåte til fremstilling derav
FI972988A (fi) Menetelmiä ja farmaseuttisia koostumuksia, joissa käytetään desmetyyliselegiliiniä
BG99596A (en) Preparation for the treatment of gums and teeth